Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of D-Glutamate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 5/20 | 0.64 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.64 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | GRM8 | O00222 | 2/20 | 0.64 |
| ▸ | GRM6 | O15303 | 2/20 | 0.64 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.64 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.64 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.64 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.64 |
| ▸ | GSR | P00390 | 2/20 | 0.64 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.64 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.64 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.64 |
| ▸ | GRM5 | P41594 | 1/20 | 0.64 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.64 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.64 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.64 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.64 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glutamic Acid SCHEMBL18249491 | 1.00 | SLC1A3 (0.64) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| D-Glutamate SCHEMBL28525856 | 1.00 | SLC1A3 (0.64) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL6130437 | 0.94 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL24357 | 0.94 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL1126187 | 0.94 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| D-Glutamate SCHEMBL3512077 | 0.94 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| Glutamic Acid SCHEMBL5614072 | 0.94 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| D-Glutamate SCHEMBL9176409 | 0.94 | SLC1A3 (0.72) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| D-Glutamate SCHEMBL28407836 | 0.92 | SLC1A3 (0.55) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 | |
| D-Glutamate SCHEMBL19876607 | 0.91 | SLC1A3 (0.67) | SLC1A3SLC1A2SLC1A1CYP1A2GRM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111936550-B | Decomposable polyethylene glycol derivative | 日油株式会社 | 2023-11-28 | — | — | CN | disclosed |
| US-20210147624-A1 | DEGRADABLE POLYETHYLENE GLYCOL DERIVATIVE | NOF CORPORATION (JP) | 2021-05-20 | — | — | US | disclosed |
| EP-3778705-A1 | DEGRADABLE POLYETHYLENE GLYCOL DERIVATIVE | NOF Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
| EP-3778628-A1 | DEGRADABLE POLYETHYLENE GLYCOL CONJUGATE | NOF Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20210023231-A1 | DEGRADABLE POLYETHYLENE GLYCOL CONJUGATE | NOF CORPORATION (JP) | 2021-01-28 | — | — | US | disclosed |
| CN-112135838-A | Degradable polyethylene glycol conjugates | 日油株式会社 | 2020-12-25 | — | — | CN | disclosed |
| CN-111936550-A | Degradable polyethylene glycol derivative | 日油株式会社 | 2020-11-13 | — | — | CN | disclosed |
| WO-2019189853-A1 | DEGRADABLE POLYETHYLENE GLYCOL CONJUGATE | 日油株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019189854-A1 | DEGRADABLE POLYETHYLENE GLYCOL DERIVATIVE | 日油株式会社 | 2019-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210023231-A1 | DEGRADABLE POLYETHYLENE GLYCOL CONJUGATE | LNPEP, CD68, CD4 | SLC1A3 724/4885SLC1A2 721/4885SLC1A1 473/4885 |
| US-20210147624-A1 | DEGRADABLE POLYETHYLENE GLYCOL DERIVATIVE | LNPEP, CD68, VMP1 | SLC1A3 760/4885SLC1A2 691/4885SLC1A1 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.